As of December 31, 2022, SynBiotic SE has 4.59M shares outstanding.
| Shares Outstanding | 4.59M |
As of December 31, 2022, SynBiotic SE maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.40 |
| Quick Ratio | 0.53 |
| Debt / Equity | 19.53 |
As of the close on October 22, 2026, SynBiotic SE's stock has declined approximately 94.07% over the past 52 weeks. The 50-day moving average sits at 0.77, while the 200-day moving average is 1.53.
| 52-Week Price Change | -94.07% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.53 |
As of December 31, 2022, SynBiotic SE holds 3.03M in cash and equivalents against 4.45M in total debt, resulting in a net debt position of 2.77M. Total book value stands at 22.59M, with working capital of 2.31M providing operational flexibility.
| Cash & Cash Equivalents | 3.03M |
| Total Debt | 4.45M |
| Net Debt | 2.77M |
| Equity (Book Value) | 22.59M |
| Book Value Per Share | 4.93 |
| Working Capital | 2.31M |
SynBiotic SE's most recent stock split took place on August 25, 2023.
| Last Split Date | 8/25/2023 |
Already premium?